click below
click below
Normal Size Small Size show me how
Pain,Hem, Oncology 1
| Generic | Brand | Category | Indication | KSE | US Box | US Box + |
|---|---|---|---|---|---|---|
| fentanyl (transdermal, IV) | Transdermal: Duragesic, IV: Sublimaze | Opioid analgesic | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warnings (Opioids): risk of addiction, abuse, and misuse → overdose/death; serious respiratory depression; fatal if accidentally ingested; neonatal withdrawal w/ prolonged use; abrupt stop → withdrawal; combo w/ CNS depressants → coma/death. | US Boxed Warning (only for fentanyl): potential for medication errors when converting between dosage forms; use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase fentanyl concentrations; avoid exposing transdermal patch to external heat |
| hydromorphone (PO, IV) | Dilaudid | Opioid analgesic | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warnings (Opioids): risk of addiction, abuse, and misuse → overdose/death; serious respiratory depression; fatal if accidentally ingested; neonatal withdrawal w/ prolonged use; abrupt stop → withdrawal; combo w/ CNS depressants → coma/death. | US Boxed Warning (only for hydromorphone): risk of medication errors with high-potency hydromorphone, use in opioid-tolerant patients only |
| morphine (extended release) (PO) | MS Contin, Kadian | Opioid analgesic | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warnings (Opioids): risk of addiction, abuse, and misuse → overdose/death; serious respiratory depression; fatal if accidentally ingested; neonatal withdrawal w/ prolonged use; abrupt stop → withdrawal; combo w/ CNS depressants → coma/death. | US Boxed Warning (only for morphine, extended release): coingestion with alcohol may result in potentially fatal overdose of morphine |
| morphine (immediate release) (PO, IV, IM, PR) | IV: Duramorph, Infumorph | Opioid analgesic | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warnings (Opioids): risk of addiction, abuse, and misuse → overdose/death; serious respiratory depression; fatal if accidentally ingested; neonatal withdrawal w/ prolonged use; abrupt stop → withdrawal; combo w/ CNS depressants → coma/death. | |
| oxycodone (PO) | OxyContin, Roxicodone | Opioid analgesic | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | US Boxed Warnings (Opioids): risk of addiction, abuse, and misuse → overdose/death; serious respiratory depression; fatal if accidentally ingested; neonatal withdrawal w/ prolonged use; abrupt stop → withdrawal; combo w/ CNS depressants → coma/death. | US Boxed Warning (only for oxycodone): use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations |
| methadone (PO, IV) | Dolophine | Opioid analgesic | Opioid use disorder, severe chronic pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related), QTc prolongation | US Boxed Warnings (Opioids): risk of addiction, abuse, and misuse → overdose/death; serious respiratory depression; fatal if accidentally ingested; neonatal withdrawal w/ prolonged use; abrupt stop → withdrawal; combo w/ CNS depressants → coma/death. | US Boxed Warnings (Methadone): QTc prolongation and serious arrhythmia (Torsades de Pointes) may occur; use with or stopping CYP3A4, 2B6, 2C19, or 2D6 inhibitors/inducers can ↑ methadone levels and risk of fatal cardiac events. |
| acetaminophen (PO, PR, IV) | PO/PR: Tylenol, IV: Ofirmev | Analgesic (non-opioid), antipyretic | Pain, fever | Key Side Effects: nausea, vomiting, increased hepatic transaminases | US Boxed Warnings: total daily dose from all sources should not exceed maximum daily limit; hepatotoxicity | |
| tramadol (PO) | Ultram, Ultram ER | Central analgesic; partial opioid agonist | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related) | US Boxed Warnings: risk of addiction, abuse, and misuse → overdose/death; serious or fatal respiratory depression; accidental ingestion may be fatal; prolonged use in pregnancy → neonatal withdrawal; combo w/ CNS depressants → coma/death. | Use or discontinuation of CYP3A4 inducers/inhibitors or 2D6 inhibitors requires caution; may ↑ toxicity or ↓ efficacy. Fatal respiratory depression reported in ultra-rapid metabolizer children after tonsillectomy/adenoidectomy using tramadol. |